Young Li
Stock Analyst at Jefferies
(1.42)
# 3,252
Out of 4,711 analysts
5
Total ratings
66.67%
Success rate
-5.95%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $33.66 | +113.90% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $93.44 | +23.07% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.89 | +41.23% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $43.12 | +39.15% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $16.31 | +182.04% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $33.66
Upside: +113.90%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $93.44
Upside: +23.07%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.89
Upside: +41.23%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $43.12
Upside: +39.15%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $16.31
Upside: +182.04%